The company is focused on the discovery, development and commercialization of monoclonal antibodies
Collaborations
In order to optimize its strategic position as well as to guarantee access to drug targets in the mid- and long-term, MediaPharma maintains a well-established network of specialists.
MediaPharma's scientists have developed and continue to expand an international network of scientists and institutes, which have access to clinically interesting and relevant targets.
Among these are for example the Max-Planck Institute of Martinsried in Germany and the Istituto Superiore di Sanità.
These relationships are strengthened through joint co-operation projects, agreements and joint applications for third party funds.
Tag Cloud
Subscribe to Rss Feed
ShareMediaPharma S.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
